Algeria-based pharmaceutical manufacturing and distribution company Biopharm, which is backed by private equity firms Development Partners International (DPI), EuroMena and Mediterrania Capital Partners (MCP), has completed a listing on the Algiers Stock Exchange. The shares listed represent 20 percent of the company’s equity and are valued at DZD6.3 billion (approximately US$57 million). DPI, EuroMena and MCP, along with development finance institution DEG, invested in the company in 2014. The firms remain shareholders in Biopharm post listing.